Scott Max Herbig,Sriram Krishnaswami,Joseph Kushner, IV,Manisha Lamba,Thomas C Stock
申请号：
US14211659
公开号：
US09937181B2
申请日:
2014.03.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to oral sustained release formulations of tofacitinib and pharmaceutical acceptable salts thereof. The formulations described herein have desirable pharmacokinetic characteristics.
